Vertex Pharmaceuticals (VRTX)

EBITDA Margin

43.45%

Quarterly · Period ending:

VRTX logo

VRTX EBITDA Margin

Latest reported43.45%
VRTX Quarterly EBITDA Margin (100.00% → 43.45%)
High-resolution chart · PNG

VRTX ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals EBITDA Margin — Quarterly
Period endingEBITDA Margin
-67.1035%
-67.5447%
-59.4042%
-92.7304%
31.22%
-211.9633%
13.8514%
-152.0833%
-76.4902%
-480%
-93.1624%
-5.4348%
-118.0556%
-356.25%
-49.1071%
-34.8148%
-3.2787%
-69.5652%
-100%
-227.5862%
-238.7097%
-312%
-15.8537%
-304.3478%
-147.6923%
-96.0784%
-274.0741%
-46.1538%
-93.75%
-41.0714%
53.8889%
-45.4545%
2.1739%
-300%
-220%
-190%
-150%
-166.6667%
-150%
-125%
-100%
100%
-966.6667%
100%
100%
100%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.